Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

BZ 2024 wrapped

8 Jan 2025
Antibodies | ADCs Automation Biomarkers Cell and gene therapies Chromatography Clinical Drug development Expert opinion General interest Interviews MS (LC–MS/MS, HRMS, IMS) News Oligonucleotides

2024 was quite the year for the bioanalytical community. For this year’s summary, we’ve put together a new and exclusive feature to say thank you for your continued support as our audience. Check out our mood board below, offering a visual summary of the year’s top bioanalysis content.

Simply zoom in and click on your favorite features to find out more!

BZ 2024 WRAPPED (2)

Top content

  • Major M&A deals impacting bioanalysis in 2026
  • Merck snaps up Terns Pharmaceuticals to expand its oncology pipeline
  • Ask the Experts: quantifying translational biomarkers

Related tags

2024 wrapped bioanalysis
Previous article Next article

Related articles

2 NOV 2017 NEWS
An evening with Bioanalysis!
5 JAN 2018 NEWS
2017 review – top 5 features on Bioanalysis Zone
Robert MacNeill
31 JAN 2025 EXPERT OPINION
eBook: A decade of experiences from Robert MacNeill
28 FEB 2020 NEWS
Frontage expand bioanalytical capabilities to support drug development, biomarker testing and high throughput sample management
5 DEC 2018 JOURNAL ARTICLES
Incurred sample reproducibility: 10 years of experiences: views and recommendations from the European Bioanalysis Forum
5 MAR 2018 INTERVIEWS
International Women’s Day: A day in the life of…Fan Jin
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone